PV-0041: Hand grip strength: independent prognostic selection test for OS in stage I NSCLC treated with SBRT

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Norms for hand grip strength.

Norms for hand grip strength of healthy children are presented. Sex and age specific centiles for age 5 to 18 years have been determined using a portable strain gauge dynamometer with an accuracy of 0.5 N. The test group comprised 1417 healthy, urban school children from a middle class suburb of Brisbane. Mean maximum grip strength (of four tests, two with each hand) and mean peak grip strength...

متن کامل

Stage I NSCLC: elucidating the prognostic factors.

Non-small cell lung cancer (NSCLC) remains the number one cause of cancer related deaths. While early stage NSCLC portends the best survival following complete surgical resection, as many as 37% of patients with stage I disease have recurrence within 5 years of diagnosis. Several studies have investigated the role of adjuvant chemotherapy for early stage disease. However, the benefit of adjuvan...

متن کامل

Muscle strength: clinical and prognostic value of hand-grip dynamometry.

PURPOSE OF REVIEW Grip strength measured by dynamometry is well established as an indicator of muscle status, particularly among older adults. This review was undertaken to provide a synopsis of recent literature addressing the clinical and prognostic value of hand-grip dynamometry. RECENT FINDINGS Numerous large-scale normative grip strength projects have been published lately. Other recent ...

متن کامل

Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose Radiotherapy

Background. The main attention regarding prognostic and predictive markers in NSCLC directs towards the EGFR-targeted pathway, where the most studied genetic alterations include EGFR mutations, EGFR copy number, and KRAS mutations. We wanted to explore the prognostic impact of mutated KRAS in the stage III setting treated with high-dose radiochemotherapy. Methods. Samples were obtained from pat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Radiotherapy and Oncology

سال: 2018

ISSN: 0167-8140

DOI: 10.1016/s0167-8140(18)30351-7